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Single-cell transcriptomics can provide quantitative molecular signatures for large,
unbiased samples of the diverse cell types in the brain1–3. With the proliferation of
multi-omics datasets, a major challenge is to validate and integrate results into a
biological understanding of cell-type organization. Here we generated transcriptomes
and epigenomes from more than 500,000 individual cells in the mouse primary motor
cortex, a structure that has an evolutionarily conserved role in locomotion. We
developed computational and statistical methods to integrate multimodal data and
quantitatively validate cell-type reproducibility. The resulting reference atlas—
containing over 56 neuronal cell types that are highly replicable across analysis
methods, sequencing technologies and modalities—is a comprehensive molecular and
genomic account of the diverse neuronal and non-neuronal cell types in the mouse
primary motor cortex. The atlas includes a population of excitatory neurons that
resemble pyramidal cells in layer 4 in other cortical regions4. We further discovered
thousands of concordant marker genes and gene regulatory elements for these cell
types. Our results highlight the complex molecular regulation of cell types in the brain
and will directly enable the design of reagents to target specific cell types in the mouse
primary motor cortex for functional analysis.

The cellular components of brain circuits are extraordinarily diverse5,6.
Single-cell molecular assays, especially transcriptomic measurements
by RNA sequencing (RNA-seq), have accelerated the discovery of cell
types across brain regions and in diverse species7. Recent advances
include single-cell transcriptomic datasets with more than 105 individual cells, identifying hundreds of neuronal and non-neuronal cell types
across the mouse nervous system1–3. As the number of profiled cells
grows into the millions, a key question is whether these data will converge towards a comprehensive, coherent taxonomy. Although a comprehensive cell atlas should incorporate anatomical and physiological

information, the high throughput of single-cell sequencing assays presents an opportunity for establishing a broad-based transcriptomic and
epigenomic cell atlas. Molecular and genomic cell signatures will drive
progress across modalities and help to obtain functional information.
Within the BRAIN Initiative Cell Census Network (BICCN), we aim
to create an atlas of cell types across the brain of several mammalian
species by integrating multiple single-cell omics approaches. We
selected the primary motor cortex (MOp) (Extended Data Fig. 1a–d)
as the starting point for our joint efforts owing to its relatively conserved structure and function across mammalian species. The MOp
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lacks species-specific cellular structures, such as the whisker barrels
in the rodent primary somatosensory cortex and the elaborate layer
4 (L4) with multiple sublayers in the primate primary visual cortex.
Traditionally, the MOp is considered to lack a cytoarchitechtonically
defined granular layer (L4), although neurons in the MOp with L4-like
connectivity have been identified4. Our mouse MOp atlas is a case study
of the expansive potential and the technical limitations of single-cell
molecular methods for comprehensive brain-wide analysis of cell types.
Single-cell transcriptomics identifies cell-type marker genes and
gene modules that shape functions such as the mode of synaptic
communication8. Epigenomic measurements of DNA methylation
and open chromatin provide signatures of gene regulation, including
non-coding regulatory regions such as enhancers. Neurons acquire
unique patterns of CG and non-CG DNA methylation during postnatal
development9,10 and have cell-type-specific open chromatin11. Together,
transcription and epigenetic modifications establish attractors in a
cell-state space that corresponds to cell types12,13. Here we integrated
large-scale single-cell transcriptomic and epigenomic datasets to
achieve a reference taxonomy for the adult mouse MOp.

Multimodal molecular census of mouse MOp
We produced nine datasets, including seven single-cell or single-nucleus
transcriptomic dataset (single-cell RNA-seq (scRNA-seq) and
single-nucleus RNA-seq (snRNA-seq) using 10x v2, v3 and SMART-Seq
v4; n = 526,373 high-quality cells), one single-nucleus DNA methylation
dataset (snmC-seq2; n = 9,872) and one single-nucleus open chromatin
dataset (single-nucleus assay for transposase-accessible chromatin
using sequencing (snATAC-seq); n = 81,196) (Extended Data Fig. 1e, f,
Supplementary Table 1). These span a range of technologies, assaying
different numbers of cells, with different depths of sequence coverage
per cell, and assessing different biological features (Fig. 1a). The datasets
reflect the trade-off between the number of sequenced molecules per
cell, which depends on cell size and the efficiency of RNA or DNA capture, and the total number of cells that can be assayed for a fixed total
cost. Our datasets include single-nucleus transcriptomes from over
175,000 cells (using the 10x Chromium 3′ v3 platform), which captures
a median of 3,100–12,700 unique molecular identifiers (UMIs) per cell.
By contrast, full-length transcript sequencing using SMART-Seq v4
captured a greater number of unique molecular fragments per cell (1 million–2.1 million), but covered fewer cells (approximately 6,300 cells per
dataset). Data on single-nucleus DNA methylation provided deep coverage of the epigenome per cell (median of 1.66 million unique sequenced
DNA fragments, covering 6.2% of the genome) for a modest number of
cells9,14 (approximately 9,800 cells). Finally, snATAC-seq data scaled to
over 81,000 cells but sampled fewer DNA fragments for individual cells
(median of 3,778 unique fragments per cell; Supplementary Table 1)11.
Subsampling RNA-seq datasets (Extended Data Fig. 2b, Supplementary Table 1) showed that scRNA-seq generally detects more genes per
cell (up to approximately 7,100 median genes per cell for 10x and 10,000
for SMART) than snRNA-seq (up to approximately 4,000 for 10x and
5,800 for SMART). The 10x v3 platform detected 60–100% more genes
than 10x v2. The number of genes detected per cell in the snRNA-seq 10x
v3 B dataset (median of approximately 4,000 genes), using an improved
nucleus isolation protocol15 (Methods), was substantially higher than the
other snRNA-seq datasets (1,700–3,500 genes) and was similar to the
scRNA-seq 10x v3 dataset when compared at the same sequencing depth.
We created web resources to interactively access, explore, visualize
and analyse the raw and processed datasets (Extended Data Fig. 1g, h).

A consensus transcriptomic atlas of MOp
To establish a transcriptomic reference atlas of the mouse MOp, we
jointly analysed seven scRNA-seq and snRNA-seq datasets. The datasets were mutually consistent, with strongly correlated expression of
104 | Nature | Vol 598 | 7 October 2021

cell-type marker genes (Extended Data Fig. 2a, d, e) despite different
sensitivity to genes with low expression (Extended Data Fig. 2c). We
used computational data integration (Methods) to jointly cluster and
identify 116 cell types using all the datasets (Fig. 1b, c, Extended Data
Fig. 2d, Supplementary Tables 2, 3). Cells and nuclei, assayed by each
of the technologies and in each batch, grouped primarily by cell type
and not by dataset (Fig. 1b). Residual systematic differences between
nuclear and cellular RNA-seq assays were observed in some clusters as
a gradient of transcriptomes from different datasets. We performed
hierarchical clustering to uncover the relationships among types within
each major cell class: GABAergic inhibitory neurons (n = 59 types),
glutamatergic excitatory neurons (n = 31) and non-neurons (n = 26)
(Fig. 1d). Six of the transcriptomic datasets used cell-sorting strategies to enrich neurons relative to non-neuronal cells, while the largest
dataset (snRNA-seq 10x v3 B) represents an unbiased sample of both
neuronal and non-neuronal cells. Despite these differences, the relative frequency of cell types was highly consistent across datasets after
normalizing for the total sample of each major class (Supplementary
Table 3). Most cell types (86 out of 116) were present in all of the datasets,
whereas the rest were non-neuronal types that were under-sampled in
many datasets or were extremely rare types (less than 0.01% of all cells).
To facilitate the use of these cell types by investigators, we adopted
a nomenclature that incorporates multiple anatomical and molecular identifiers. For example, we identified four clusters of excitatory
neurons (expressing Slc17a7, which encodes the vesicular glutamate
transporter VGLUT1) that express a deep layer marker, Fezf2, as
well as Fam84b, which is a unique marker of the pyramidal tract3 or
extratelencephalically- projecting neurons (ET) 16 (Fig. 1e). Thus, we
labelled these neurons ‘L5 ET 1–4’. We divided GABAergic neurons into
five major subclasses based on marker genes: Lamp5, Sncg and Vip,
which label cells derived from the caudal ganglionic eminence, and
Sst and Pvalb, which label cells derived from the medial ganglionic
eminence. Finer distinctions among GABAergic types are identified
by secondary markers (for example, Sst and Myh8). Tables of cluster
accession IDs and differentially expressed genes between every pair
of cell types help to track the cell types and their underlying molecular
evidence17 (Supplementary Tables 3, 6).
We compared our MOp atlas with a large dataset of neurons from
the mouse anterolateral motor cortex and the primary visual cortex
assayed by scRNA-seq (SMART-Seq)3 (Extended Data Fig. 3a). We found
one-to-one matches between most of the 116 MOp cell types and the 102
cell types previously defined in the anterolateral motor cortex. Four
types of L5 ET neurons correspond with three previously described
deep layer excitatory neurons with distinct subcortical projection
patterns to the thalamus and the medulla18 (Extended Data Fig. 3b, c).
These types, which were associated with distinct roles in movement
planning and initiation, had consistent patterns of differential gene
expression across the transcriptomic datasets (Extended Data Fig. 4).
The motor cortex is traditionally considered to lack a discernible L4
based on the absence of a clear cytoarchitectonic signature19. However,
recent anatomical studies have identified a population of pyramidal
cells located between L3 and L5, with hallmarks of L4 neurons including thalamic input and outputs to L4 and L2/3 (ref. 4). We identified two
intratelencephalically projecting (IT) clusters, containing over 99,000
cells, which express a combination of markers usually associated with
L4 (ref. 20), including Cux2, Rspo1 and Rorb (both clusters), and those
associated with L5, for example, Fezf2 (one cluster) (Fig. 1e, Extended
Data Fig. 5a). We confirmed the specificity of the expression of these
genes in the MOp by in situ hybridization (Extended Data Fig. 5b). These
cells represent a substantial fraction (18% or more) of all excitatory
neurons in each dataset. Therefore, we labelled these clusters L4/5.
Moreover, the localization of cells with these gene markers in middle
layers is further supported by spatial transcriptomics21.
Using our integrated dataset, we directly compared the nuclear and
cytoplasmic transcriptomes of MOp cells. Both modalities can achieve
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Fig. 1 | Multi-platform transcriptomic taxonomy of the cell types in the
MOp. a, Key attributes of nine single-cell transcriptomic and epigenomic
datasets from the mouse MOp. b, c, Two-dimensional projection (uniform
manifold approximation and projection (UMAP)40) of cells and nuclei based on
integrated analysis of seven transcriptomic (scRNA-seq and snRNA-seq)
datasets. Cells and nuclei are coloured by dataset (b) using the colours shown in
a, or by cell type (c). Non-neuronal cell types are depleted owing to the sampling
strategy, which enriched neurons in all datasets except snRNA 10x v3 B.
d, Dendrogram showing a hierarchical relationship among the consensus
transcriptomic cell types and a proportion of cells of each type per dataset,
normalized within major classes. Glu, glutamatergic. e, Expression of selected
marker genes for excitatory (top) and inhibitory (bottom) cell classes, across

four platforms. f, Differential enrichment of transcripts in single cells versus
single nuclei. The long non-coding RNA Malat1 is enriched in nuclei. CPM,
counts per million reads mapped. g, The number of replicable clusters across at
least two of the seven scRNA-seq and snRNA-seq datasets as a function of the
minimal MetaNeighbor score (AUROC). h, The trade-off between the number of
clusters and replicability (the per cent of clusters with minimal MetaNeighbor
replicability score). The major inhibitory neuron subclasses are Lamp5, Sncg,
Vip, Sst and Pvalb. Astro, astrocyte; CT, corticothalamic; endo, endothelial; ET,
extratelencephalically projecting; IT, intratelencephalically projecting;
micro, microglial cell; NP, near-projecting; oligo, oligodendrocyte; OPC,
oligodendrocyte precursor cell; peri, pericyte; PVM, perivascular macrophage;
SMC, smooth muscle cell; VLMC, vascular leptomeningeal cell.

comparable clustering resolution (Extended Data Fig. 2d), as previously
reported22, but they provide distinct information about some cell types
and transcripts. We found that the long non-coding RNA Malat1 was
enriched in snRNA-seq, consistent with its nuclear localization23 (Fig. 1f,

Extended Data Fig. 2f). By contrast, mRNA of the protein-coding gene
Ywhaz was strongly depleted from the nucleus.
We used MetaNeighbor to assess the cross-dataset replicability of
clusters defined separately using each of the seven transcriptomic
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datasets24 (Supplementary Table 4). We found 70 clusters with a
high replicability (area under receiver operating characteristic
(AUROC) > 0.7 across at least two datasets) (Fig. 1g). Most clusters had
reciprocal best matches across all datasets (Extended Data Fig. 8a). By
comparing the results of three different widely used single-cell analysis
packages25–27, we found lower replicability for fine-grained partitions
of cells into 30 or more clusters (Fig. 1h). These results highlight the
importance of careful biologically informed cluster analyses.

Combining transcriptomes and epigenomes
Regions of open chromatin and patterns of DNA methylation, including CG and non-CG methylation, are cell-type-specific signatures of
neuronal identity and can be assayed in single nuclei9,11. We applied
snmC-seq2 (ref. 14) (9,876 cells) and snATAC-seq28 (81,196 cells) assays
to nuclei isolated from the same MOp samples. Independent analyses of each epigenomic dataset identified n = 42 cell types using DNA
methylation, and n = 33 cell types using open chromatin (Extended Data
Fig. 6a–d, Supplementary Table 4). Marker genes for major cell classes
had corresponding patterns of cell-type-specific depletion of non-CG
methylation (low mCH; Extended Data Fig. 6b) and open chromatin in
the gene body (Extended Data Fig. 6d).
We integrated eight transcriptomic and epigenomic datasets using
two computational methods (linked inference of genomic experimental relationships (LIGER)29 and SingleCellFusion30) to produce a unified, multimodal cell census (Fig. 2a–c, Extended Data Figs. 6e–j, 7a, b,
Supplementary Table 5). We reasoned that cells of the same type measured in each modality can be identified based on correlated gene-centric
features. Gene expression is negatively correlated with gene body
non-CG methylation9 and positively related to the gene body and promoter ATAC-seq read density31. Although distal regulatory elements
(for example, enhancers) were not used for dataset integration, they
were subsequently analysed at the level of integrated cell types.
By combining cells from integrated clusters into pseudo-bulk tracks,
we obtained base-resolution epigenomic and transcriptomic information (Fig. 2f, g) (https://brainome.ucsd.edu/BICCN_MOp). To illustrate,
we highlight the locus of Tac1, which encodes a precursor of the neuropeptide substance P and marks a subset of interneurons derived from
the medial ganglionic eminence32. We confirmed Tac1 mRNA expression
in parvalbumin-expressing neurons marked by Reln and Calb1. We
further observed accessible chromatin and low DNA methylation at CG
sites within the body of the Tac1 gene and at a location approximately
24 kb upstream of the transcription start site (Fig. 2f).
Both computational integration methods (LIGER and SingleCellFusion) identified 56 cell types, which showed a high degree of concordance between the methods and with the transcriptome-based consensus
clusters (Extended Data Fig. 7a–d). Indeed, integrated analysis identified
more cell types than the single-modality analysis of each epigenomic
dataset, while largely concurring with the independent clusters (Extended
Data Fig. 7b). Integration revealed notable examples of cross-modal
cell-type-specific signatures. For example, Tshz2 is a specific marker of L5
near-projecting excitatory neurons, with low DNA methylation (mCG and
mCH), open chromatin and strong cell-type-specific expression (Fig. 2d,
e, g). The close correspondence between transcriptomic and epigenomic
signatures at Tshz2, and at 35 markers of other cell types, was evident
across each of the datasets (Fig. 2d). Importantly, these pseudo-bulk
tracks include data, such as CG methylation and intergenic snATAC-seq
signals, that were not used for the multimodal computational integration.
In addition to concordant cross-modal signals, we also found loci
where transcriptomic and epigenomic data diverged. For instance, at
Lhx9, we found high DNA methylation in L6b excitatory neurons, with little or no methylation in any other cell type (Fig. 2g, Extended Data Fig. 7f).
Despite this cell-type-specific DNA methylation, we found no expression
of Lhx9 RNA in any cell type and no significant enrichment of ATAC-seq
reads. Lhx9 has been implicated in early developmental patterning of
106 | Nature | Vol 598 | 7 October 2021

the caudal forebrain and may be transcriptionally silenced in the adult,
potentially through Polycomb-mediated repression33. Other regulators
of neural development, such as Pax6 and Dlx1/2, have a similar epigenetic profile with cell-type-specific hypermethylation. This pattern may
represent a vestigial epigenetic signature of embryonic development34.

Cell-type-specific epigenomic marks
Epigenomic data identify potential regulatory regions, such as distal enhancers, marked by open chromatin and low DNA methylation
(mCG). These modalities have complementary technical characteristics, such as the number of cells assayed (higher for open chromatin)
and the genomic coverage per cell (higher for DNA methylation; Fig. 1a).
We first defined differentially methylated regions (DMRs) and chromatin accessibility peaks independently, identifying over 1.3 million
DMRs covering 225 Mb (8.3% of the genome) and 300,000 accessible
regions (170 Mb) (Fig. 3a, b). In each cell type, a large fraction of accessible regions (28–89%) overlapped hypomethylated DMRs (Fig. 3a). By
contrast, many DMRs did not overlap accessibility peaks (Fig. 3b). In
some cases, these DMRs coincided with broad open chromatin regions,
such as whole gene bodies, which had no narrow ATAC peaks.
By downsampling data from two abundant cell types (L2/3 IT and
L6 CT neurons), we found that the number of detectable accessibility
peaks was saturated after sampling around 1,000 cells (Fig. 3c). By
contrast, the number of DMRs reached a plateau after sampling 200–
300 cells (Fig. 3d). Furthermore, the number of significantly enriched
transcription factor motifs increased with the number of cells (Fig. 3e);
although for L6 CT neurons, it reached a plateau of approximately five
key motif families after sampling around 100 cells.
Combining both epigenomic datasets, we identified 250,000 putative enhancers with fine resolution35 (Supplementary Table 7). Putative
enhancers were often found in distal regions, at least 2 kb from the nearest transcription start site (Fig. 3h, i). Sequence motifs of several transcription factor families were enriched in each cell type (Fig. 3f), such
as Rfx motifs in L2/3 neurons. Using the transcriptomic data, we found
that Rfx3, but not other Rfx family members, was specifically enriched
in L2/3 neurons and had low methylation and accessible chromatin in
the gene body as well as approximately 15 kb upstream of the Rfx3 promoter (Fig. 3g). These data suggest a key role for Rfx3 in L2/3 neurons.

Reproducible cell types across datasets
Different molecular modalities, sampling strategies, sequencing technologies and computational analysis procedures can lead to divergent estimates of the total number of cell types. We used systematic
cross-dataset analyses to assess the statistical and biological reproducibility of cell types and constrain the range of plausible numbers of cell
types based on current single-cell sequencing data.
We first addressed the effect of the number of sampled cells on the
resolution of the cell atlas, by downsampling each dataset followed by
clustering analysis with a fixed resolution parameter (Fig. 4a). The number of detected neuronal cell types (clusters) increased logarithmically
with cell number, with relatively few additional clusters detected after
sampling approximately 80,000 cells or nuclei. Notably, the dependence of the number of clusters on the number of sampled cells was
similar for all modalities and datasets, showing that the number of
sampled cells is a key determinant of cluster resolution.
Any dataset can be divided into increasingly fine-grained clusters, yet
they may not reflect biologically meaningful or reproducible cell-type
distinctions. We used cross-validation to objectively measure the generalizability of cluster-based descriptions of the data (Extended Data Fig. 8b).
We first used within-dataset cross-validation, dividing the features (genes
or genomic bins) into clustering and validation sets. After clustering all
cells using the clustering feature set, we split the cells into training and
test sets. We used the training cells to learn the validation set features
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or gene expression. See https:bit.ly/3bABMX2 for
Tshz2 and https://bit.ly/2HioFMv for Lhx9.
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for each cluster. Finally, we compared the validation set features with the
held-out data for test cells to measure the mean squared error. We applied
this procedure to each dataset with a range of clustering resolutions,
resulting in a U-shaped cross-validation curve for the test set error as a
function of the number of clusters (Fig. 4b, Extended Data Fig. 8c, d). The
location of the minimum mean squared error is an estimate of the number

of reliable clusters. Finally, we repeated this cross-validation procedure
for each dataset in combination with systematic downsampling (Fig. 4c).
All of the datasets (except snRNA SMART-Seq) supported approximately 100 or more cell types when a sufficient number of cells was
sampled. The number of cells required to achieve this resolution was
larger for snATAC-seq (with few reads per cell) than for RNA-seq or
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Fig. 3 | Epigenomic signatures of regulatory elements in the MOp.
a, b, Regulatory regions were identified in each cell type using DMRs
(n = 1,302,403) (a) and open chromatin regions (ATAC peaks; n = 316,788) (b)
in multimodal integrated clusters. c, d, Saturation analysis for two excitatory
subclasses shows the number of regulatory regions detected as a function
of sampled cells. e, Saturation analysis of the number of transcription
factor DNA-binding sequence motifs enriched in DMRs of each cell type.

f, Enrichment of motifs for selected transcription factor families as a function
of the number of cells sampled. g, Browser views of loci containing cell-typespecific regulatory elements (grey highlighted regions). The Rfx3 gene is
differentially expressed in L2/3 neurons and has an enhancer specific to L2/3
located approximately 15 kb upstream of the promoter region. h, i, Examples of
intergenic regions with accessibility and demethylation specific to L6 CT (h) or
L2/3 (i) neurons. The black bars indicate predicted regulatory regions.

snmC-seq2. This observation is consistent with the relative sparseness
of the snATAC-seq data. We further found that scRNA-seq and snRNA-seq
datasets with the largest numbers of cells could support very high cluster
resolution with up to approximately 600 clusters. Our cross-validation
analysis shows that these fine-grained clusters capture genuine transcriptomic structure, which is correlated and replicable across cells and across
genomic features. However, at least some of this structure probably corresponds to continuous variation within discrete cell types, rather than
discrete cell-type categories36. Moreover, the cross-validation analysis
shows no sharp error minimum at a particular value of the number of
clusters. Instead, the U-shaped cross-validation curve has a broad basin
covering a range of plausible values (Fig. 4b, Extended Data Fig. 8c, d).
To more stringently test the reproducibility of cell types, we performed cross-dataset cross-validation (Extended Data Fig. 8b). This
procedure uses a randomly chosen half of genomic features to perform
data integration and joint analysis of eight datasets using SingleCellFusion. Next, we used the joint cluster labels to perform cross-validation
in each dataset, as in the within-dataset procedure above. This analysis
supported a maximum resolution of approximately 100 clusters when
testing using the scRNA SMART-Seq data (Fig. 4d).
As an alternative to joint analysis of multiple datasets, which could
potentially discern spurious correlations owing to computational data
integration, we also took a more stringent approach to cross-validation.
Using the independent cluster analysis of each dataset, we performed

MetaNeighbor analysis to assess the replicability of clusters24. We
found that the median replicability score for all clusters was high
(AUROC > 0.8) for integrated analyses with coarse resolution (less
than 50 clusters, level 1 analyses; Fig. 4e). The more fine-grained joint
analyses (level 2; 50–120 clusters) were also largely supported by
MetaNeighbor, but with a lower median replicability score around 0.7.
Notably, we found a high degree of consistency in the results of joint
cluster analysis when using different computational methods (Fig. 4f).
Finally, we explored whether cell-type signatures in the MOp were
stable across different scRNA-seq and snRNA-seq platforms. Using four
RNA-seq datasets (scRNA SMART, snRNA SMART, scRNA 10x v3 A and snRNA
10x v3 A), we performed clustering on a network of samples (Conos37) to
link cells across datasets and determine joint clusters. We compared the
clustering results based on inter-platform network connections only versus results that also included connections across datasets of the same
platform (Extended Data Fig. 8e). Most neuron types, except parvalbuminexpressing interneurons and L6 CT, had only a modest difference in cluster
stability using both approaches (Fig. 4g) and a low level of inter-platform
divergence in their cell-type transcriptomic signatures (Fig. 4h).
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Discussion
Our MOp cell atlas represents the most comprehensive, integrated
collection of single-cell transcriptomic and epigenomic datasets for a
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single brain region to date. We generated a high-resolution consensus
transcriptomic cell-type taxonomy that integrates seven scRNA-seq
and snRNA-seq datasets collected from the MOp with six experimental methods. Our transcriptomic taxonomy is highly consistent with
a previously published transcriptomic cell census from the primary
visual and the anterolateral motor cortices based on SMART-Seq alone3.
We found that gene expression profiles were largely consistent across
methodologies, while providing complementary information about
particular genes such as nucleus-enriched transcripts. The MOp atlas
demonstrates the power of a two-pronged strategy that combines broad
sampling of diverse cell types (for example, 10x with a large number
of cells and shallow sequencing) with deep sequencing (for example,
SMART-Seq) to precisely characterize gene expression profiles for each
cell type. This strategy should guide future cell census efforts, by the
BICCN and others, at the scale of whole brains and in other species.
We further demonstrated multimodal integration of transcriptomic
(scRNA-seq and snRNA-seq), DNA methylation (snmC-seq2) and chromatin accessibility (snATAC-seq) datasets using two computational methods (SingleCellFusion and LIGER). It is possible to directly establish links
between molecular modalities through simultaneous measurement of
multiple signatures in the same cell38. However, multimodal single-cell
assays remain challenging and often provide lower depth or resolution
of data in each modality than single-modality assays. Moreover, it is
important to show that data collected from different animals, across
different laboratories and using different experimental platforms and
assays, nevertheless can be integrated within a unified cell-type atlas. By
correlating mRNA transcripts, gene body methylation and accessibility
peaks, we showed that different types of data can be integrated without
forfeiting the resolution of more than 50 fine-grained neuron types.
Integrative analysis of transcriptional and epigenetic signatures of cell
identity will enable the development of tools based on cell-type-specific
enhancers for cell targeting and manipulation.
Our data provide new insights into the molecular architecture of
cell types in the MOp. Tac1, encoding the neuropeptide substance
P precursor, marks a subset of parvalbumin-expressing cells and is
strongly upregulated in the rodent MOp following motor learning32,39.
We found that Tac1 is expressed in two subtypes of MOp interneurons
(Pvalb_Calb1 and Pvalb_Reln), and our epigenomic data identified a
cell-type-specific enhancer approximately 24 kb upstream of the gene
promoter. We provide new evidence that the MOp has an excitatory
neuron population that expresses markers of L4 thalamic-recipient
neurons, including Cux2, Rspo1 and Rorb4. The laminar distribution of
these cells has been confirmed by in situ hybridization of these marker
genes and in a parallel study by MERFISH21. This discovery revises the
traditional understanding of the MOp as an agranular cortex lacking L4. We also found multiple types of L5 ET neurons that align with
recently described populations with distinct subcortical projection
targets18. Moreover, we identified networks of gene expression regulatory elements, marked by overlapping regions of open chromatin
and cell-type-specific demethylation, that have sequence motifs that
identify the key transcriptional regulators. For example, by combining
epigenetic and gene expression data, we identified Rfx3 as a candidate
factor for L2/3 IT cells. We also identified genes with non-canonical
regulatory signatures, such as enrichment of mCG in Lhx9, specifically
in L6b excitatory cells.
We took advantage of the unprecedented diversity of large-scale
datasets, generated in a coordinated manner from the mouse MOp, to
critically evaluate the robustness and reliability of the cell-type taxonomies obtained by clustering molecular datasets. Our cross-validation
analysis of individual datasets and multimodal integration objectively
constrains the range of cluster resolutions supported by the data without overfitting. Rather than supporting a single, definitive number of
cell types in the mouse MOp, our studies instead point to a range of
cluster resolutions spanning from approximately 30 to 116 cell types
that are supported by the data. Indeed, discrete cell-type categories
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may be an inappropriate description at a fine-grained level of analysis,
in which the molecular profiles of cells vary along a continuum.
By integrating nine large-scale single-cell transcriptomic and epigenomic datasets, we have comprehensively classified and annotated
the diversity of cell types in the adult mouse MOp. Our study demonstrates general procedures for objective cross-dataset comparison
and statistical reproducibility analysis, as well as standards and best
practices that can be adopted for future large-scale studies. Together
with complementary BICCN datasets from spatial transcriptomics,
connectivity and physiology, as well as cross-species comparative
studies, our results help to establish a multifaceted understanding
of brain cell diversity. Targeted studies of individual cell types, taking
advantage of the transcriptional and epigenetic signatures described
here, will define their functional roles and significance in the context
of neural circuits and behaviour. Integrative analyses will be essential
to make progress towards understanding the organizing principles
of cell types in the brain through their molecular genetic signatures.
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Methods
Tissue collection and isolation of cells or nuclei (RNA-seq at the
Allen Institute)
The following methods apply to the following transcriptomic datasets
generated at the Allen Institute: scRNA SMART, scRNA 10x v3 A, scRNA
10x v2 A, snRNA SMART, snRNA 10x v3 A and snRNA 10x v2 A.
Mouse breeding and husbandry. All procedures were carried out in
accordance with the Institutional Animal Care and Use Committee protocols at the Allen Institute for Brain Science. Mice were provided food
and water ad libitum and were maintained on a regular 12-h day/night
cycle at no more than five adult mice per cage. Ambient temperature
was set to 72 °F and relative humidity was set to 40%. All rooms were on
12/12-h light/dark cycle. For this study, we enriched for neurons by using
Snap25-IRES2-Cre mice41 (MGI: J:220523) crossed to Ai14 (ref. 42) (MGI:
J:220523), which were maintained on the C57BL/6J background (RRID:
IMSR_JAX:000664). Mice were euthanized at 53−59 days of postnatal
age. Tissue was collected from both males and females (scRNA SMART,
snRNA SMART, scRNA 10x v3 A and snRNA 10x v2 A), only males (scRNA
10x v2 A) or only females (snRNA 10x v3 A).
Single-cell isolation. We isolated single cells by adapting previously described procedures3,43. The brain was dissected, submerged in
artificial cerebrospinal fluid (ACSF)3, embedded in 2% agarose, and
sliced into 250-μm (SMART-Seq) or 350-μm (10x Genomics) coronal
sections on a Compresstome (Precisionary Instruments). The Allen
Mouse Brain Common Coordinate Framework version 3 (CCFv3; RRID:
SCR_002978)44 ontology was used to define the MOp for dissections
(Extended Data Fig. 1b).
For SMART-Seq, the MOp was microdissected from the slices and
dissociated into single cells with 1 mg/ml pronase (P6911-1G, Sigma) and
processed as previously described3. For 10x Genomics, tissue pieces
were digested with 30 U/ml papain (PAP2, Worthington) in ACSF for
30 min at 30 °C. Enzymatic digestion was quenched by exchanging
the papain solution three times with quenching buffer (ACSF with 1%
FBS and 0.2% BSA). The tissue pieces in the quenching buffer were
triturated through a fire-polished pipette with a 600-μm diameter
opening approximately 20 times. The solution was allowed to settle
and supernatant containing single cells was transferred to a new tube.
Fresh quenching buffer was added to the settled tissue pieces, and
trituration and supernatant transfer were repeated using 300-μm and
150-μm fire-polished pipettes. The single-cell suspension was passed
through a 70-μm filter into a 15-ml conical tube with 500 μl of high BSA
buffer (ACSF with 1% FBS and 1% BSA) at the bottom to help cushion the
cells during centrifugation at 100g in a swinging bucket centrifuge for
10 min. The supernatant was discarded, and the cell pellet was resuspended in a quenching buffer.
All cells were collected by fluorescence-activated cell sorting (FACS;
BD Aria II; RRID: SCR_018091) using a 130-μm nozzle. Cells were prepared for sorting by passing the suspension through a 70-μm filter
and adding DAPI (to the final concentration of 2 ng/ml). The sorting
strategy was as previously described3, with most cells collected using
the tdTomato-positive label. For SMART-Seq, single cells were sorted
into individual wells of eight-well PCR strips containing lysis buffer from
the SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (634894,
Takara) with RNase inhibitor (0.17 U/μl), immediately frozen on dry
ice and stored at −80 °C. For 10x Genomics, 30,000 cells were sorted
within 10 min into a tube containing 500 μl of quenching buffer. Each
aliquot of 30,000 sorted cells was gently layered on top of 200 μl of
high BSA buffer and immediately centrifuged at 230g for 10 min in a
swinging bucket centrifuge. The supernatant was removed and 35 μl
of buffer was left behind, in which the cell pellet was resuspended. The
cell concentration was quantified and immediately loaded onto the
10x Genomics Chromium controller.

Tissue collection and nuclei isolation (RNA-seq at the Broad
Institute)
These methods apply to the snRNA 10x v3 B dataset, generated at the
Broad Institute.
Animal housing. Mice were group housed with a 12-h light/dark schedule and allowed to acclimate to their housing environment for 2 weeks
after arrival. Ambient temperature was set to 70 ± 2 °F and relative
humidity was set to 40 ± 10%. All rooms are on 12/12-h light/dark cycle. All procedures involving animals at the Massachusetts Institute
of Technology were conducted in accordance with the US National
Institutes of Health Guide for the Care and Use of Laboratory Animals
under protocol number 1115-111-18 and approved by the Massachusetts
Institute of Technology Committee on Animal Care. All procedures
involving animals at the Broad Institute were conducted in accordance
with the US National Institutes of Health Guide for the Care and Use of
Laboratory Animals under protocol number 0120-09-16. Samples were
collected from both male and female mice.
Brain preparation before 10x nuclei sequencing. At 60 days of age,
C57BL/6J mice were anaesthetized by administration of isoflurane in a
gas chamber flowing 3% isoflurane for 1 min. Anaesthesia was confirmed
by checking for a negative tail pinch response. Mice were moved to a
dissection tray and anaesthesia was prolonged via a nose cone flowing
3% isoflurane for the duration of the procedure. Transcardial perfusions were performed with ice-cold pH 7.4 HEPES buffer containing
110 mM NaCl, 10 mM HEPES, 25 mM glucose, 75 mM sucrose, 7.5 mM
MgCl2 and 2.5 mM KCl to remove blood from the brain and other organs
sampled. The brain was removed immediately and frozen for 3 min in
liquid nitrogen vapour and moved to −80 °C for long-term storage. A
detailed protocol is available at protocols.io15.
Generation of MOp nuclei profiles. Frozen mouse brains were securely
mounted by the cerebellum onto cryostat chucks with OCT embedding
compound such that the entire anterior half, including the MOp, was left
exposed and thermally unperturbed. Dissection of 500-μm anterior–
posterior spans of the MOp (Extended Data Fig. 1c) was performed by
hand in the cryostat using an ophthalmic microscalpel (P-715, Feather
safety Razor) precooled to −20 °C and donning 4× surgical loupes.
Each excised tissue dissectate was placed into a precooled 0.25-ml
PCR tube using precooled forceps and stored at −80 °C. To assess dissection accuracy, 10-μm coronal sections were taken at each 500-μm
anterior–posterior dissection junction and imaged following Nissl
staining. Nuclei were extracted from these frozen tissue dissectates
using gentle, detergent-based dissociation, according to a protocol45
adapted from one generously provided by the McCarroll laboratory,
and loaded into the 10x Chromium v3 system. Reverse transcription
and library generation were performed according to the manufacturer’s
protocol.
This 10x v3 snRNA-seq protocol resulted in a higher number of genes
recovered than other snRNA-seq methods. We believe that there are
three reasons for this, and that the summation of benefits imparted by
the combination of these accounts for the outcome.
First, mouse brains were perfused with a solution emulating ACSF and
then rapidly frozen over liquid nitrogen vapour in such a way that RNA
integrity was highly preserved. The resulting bioanalyzer RIN scores
of the starting brain tissues were routinely 9.8. Storage of the brains
before dissection was at −80 °C in the presence of a hydration sink of 1
ml of OCT compound pre-frozen into the bottom of a 5-ml storage tube.
This prevents sublimation and subsequent desiccation-dependent
RNA fragmentation.
Second, we performed expeditious sample processing. We have a
well-trained group of technicians who processed the mouse brain (as
above), and then perform the dissociation, FACS and 10x processing
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(as below) in one continuous protocol without pauses. For example,
each mouse was perfused and ready for dissection within minutes (10
min), and we limited our sample size to six mice so that no sample was
waiting to move through the process.
Third, the frozen tissue snRNA-seq protocol incorporates two main
features that we believe are important to quality because they prevent
the nuclei from ‘leaking’ valuable signal and simultaneously contaminating the barcoded nuclei mixture with exogenous RNA signal. The
first feature was a very low level of centrifugation, which we have found
to cause both loss of signal and increased exogenous signal. The second
feature was the inclusion of an excipient reagent, BASF Kollidon VA-64,
as per the McCarroll laboratory protocol46.

Tissue collection and isolation of nuclei for epigenomic samples
The following methods apply to the snmC-seq2 and snATAC-seq datasets generated at the Salk Institute and the University of California,
San Diego.
Tissue preparation for nuclei production. Procedures involving
animals at the Salk Institute were conducted in accordance with the
US National Institutes of Health Guide for the Care and Use of Laboratory Animals under protocol number 18-00006 and approved by the
Institutional Animal Care and Use Committee. Male C57BL/6J mice
were purchased from Jackson laboratories at 8 weeks of age and maintained in the Salk animal barrier facility on 12-h dark/light cycles with
controlled temperature (20–22 °C) and humidity (30–70%), and food
ad libitum for 1 week before dissection.
Brains were extracted from 56 to 63-day-old mice and immediately
sectioned into 0.6-mm coronal sections, starting at the frontal pole,
in ice-cold dissection media9. The MOp was dissected from slices two
to five along the anterior–posterior axis according to the Allen Brain
reference Atlas (Extended Data Fig. 1d). Slices were kept in ice-cold
dissection media during dissection and immediately frozen in dry ice
for subsequent pooling and nuclei production. For nuclei isolation,
dissected regions of the MOp from 15 to 23 mice were pooled for each
biological replicate, and two replicates were processed for each region.
Nuclei were isolated by flow cytometry as described in previous studies9,10. In brief, nuclei were produced by homogenization in sucrose
buffer as previously described9, and the nuclei pellet produced was
divided into two aliquots. One aliquot underwent sucrose gradient
purification and NeuN labelling (snmC-seq2), and the second aliquot
went directly to tagmentation (snATAC-seq).
Bisulfite conversion and library preparation for snmC-seq2. Detailed
methods for bisulfite conversion and library preparation are previously
described for snmC-seq2 (ref. 14), and the protocol is available on protocols.io47. The snmC-seq2 libraries were sequenced using an Illumina
Novaseq 6000 instrument (RRID: SCR_016387) with S4 flowcells and
150-bp paired-end mode.
snATAC-seq data generation. Combinatorial barcoding snATAC-seq
was performed as previously described28,48. Isolated brain nuclei were
pelleted with a swinging bucket centrifuge (500g for 5 min at 4 °C;
5920R, Eppendorf). Nuclei pellets were resuspended in 1 ml nuclei permeabilization buffer (5% BSA, 0.2% IGEPAL-CA630, 1 mM dithiothreitol
and cOmplete, EDTA-free protease inhibitor cocktail (Roche) in PBS)
and pelleted again (500g for 5 min at 4 °C; 5920R, Eppendorf; RRID:
SCR_018092). Nuclei were resuspended in 500 μl high-salt tagmentation buffer (36.3 mM Tris-acetate (pH 7.8), 72.6 mM potassium-acetate,
11 mM Mg-acetate and 17.6% DMF) and counted using a haemocytometer. Concentration was adjusted to 4,500 nuclei per 9 μl, and 4,500 nuclei were dispensed into each well of a 96-well plate. For tagmentation,
1 μl of barcoded Tn5 transposomes48 were added using BenchSmart 96
(Mettler Toledo; RRID: SCR_018093), mixed five times and incubated for
60 min at 37 °C with shaking (500 r.p.m.). To inhibit the Tn5 reaction, 10

μl of 40 mM EDTA was added to each well with BenchSmart 96 (Mettler
Toledo) and the plate was incubated at 37 °C for 15 min with shaking
(500 r.p.m.). Next, 20 μl 2× sort buffer (2% BSA and 2 mM EDTA in PBS)
were added using BenchSmart 96 (Mettler Toledo). All wells were combined into a FACS tube and stained with 3 μM Draq7 (Cell Signaling).
Using a SH800 (Sony), 40 nuclei were sorted per well into eight 96-well
plates (a total of 768 wells) containing 10.5 μl EB (25 pmol primer i7, 25
pmol primer i5 and 200 ng BSA (Sigma)). Preparation of sort plates
and all downstream pipetting steps were performed on a Biomek i7
Automated Workstation (Beckman Coulter; RRID: SCR_018094). After
the addition of 1 μl 0.2% SDS, samples were incubated at 55 °C for 7 min
with shaking (500 r.p.m.). Triton-X (12.5%; 1 μl) was added to each well
to quench the SDS. Next, 12.5 μl NEBNext High-Fidelity 2× PCR Master
Mix (NEB) was added and samples were PCR-amplified (72 °C for 5 min,
98 °C for 30 s (98 °C for 10 s, 63 °C for 30 s and 72 °C or 60 s) × 12 cycles,
held at 12 °C). After PCR, all wells were combined. Libraries were purified according to the MinElute PCR Purification Kit manual (Qiagen)
using a vacuum manifold (QIAvac 24 plus, Qiagen) and size selection
was performed with SPRI Beads (0.55× and 1.5×; Beckmann Coulter).
Libraries were purified one more time with SPRI Beads (1.5×, Beckmann
Coulter). Libraries were quantified using a Qubit fluorimeter (Life Technologies; RRID: SCR_018095), and the nucleosomal pattern was verified
using a Tapestation (High Sensitivity D1000, Agilent). The library was
sequenced on a HiSeq2500 sequencer (Illumina; RRID: SCR_016383)
using custom sequencing primers, 25% spike-in library and the following read lengths: 50 + 43 + 37 + 50 (Read1 + Index1 + Index2 + Read2)11.

Genomic library preparation, sequencing and data processing
scRNA-seq and snRNA-seq (Allen Institute). For SMART-Seq processing, we performed the procedures with positive and negative controls
as previously described3. The SMART-Seq v4 Ultra Low Input RNA Kit
for Sequencing (634894, Takara) was used to reverse transcribe poly(A)
RNA and amplify full-length cDNA. Samples were amplified for 18 cycles in eight-well strips, in sets of 12–24 strips at a time. All samples
proceeded through Nextera XT DNA Library Preparation (FC-131-1096,
Illumina) using Nextera XT Index Kit V2 (FC-131-2001, Illumina) and
a custom index set (Integrated DNA Technologies). Nextera XT DNA
Library preparation was performed according to the manufacturer’s
instructions, with a modification to reduce the volumes of all reagents
and cDNA input to 0.4× or 0.5× of the original protocol.
For 10x v2 processing, we used the Chromium Single Cell 3′ Reagent Kit v2 (120237, 10x Genomics). We followed the manufacturer’s
instructions for cell capture, barcoding, reverse transcription, cDNA
amplification and library construction. We targeted a sequencing depth
of 60,000 reads per cell.
For 10x v3 processing, we used the Chromium Single Cell 3′ Reagent Kit v3 (1000075, 10x Genomics). We followed the manufacturer’s
instructions for cell capture, barcoding, reverse transcription, cDNA
amplification and library construction. We targeted a sequencing depth
of 120,000 reads per cell.
RNA-seq data processing and quality control (Allen Institute).
Processing of SMART-Seq v4 libraries was performed as previously
described3. Briefly, libraries were sequenced on an Illumina HiSeq2500
platform (paired-end with read lengths of 50 bp), and Illumina sequencing reads were aligned to GRCm38.p3 (mm10) using a RefSeq annotation gff file retrieved from the NCBI on 18 January 2016 (https://www.
ncbi.nlm.nih.gov/genome/annotation_euk/all/). Sequence alignment
was performed using STAR v2.5.349. PCR duplicates were masked and
removed using STAR option ‘bamRemoveDuplicates’. Only uniquely
aligned reads were used for gene quantification. Gene counts were computed using the R GenomicAlignments package (RRID: SCR_018096)50
and the summarizeOverlaps function in ‘IntersectionNotEmpty’ mode
for exonic and intronic regions separately. For the SMART-Seq v4 dataset, we only used exonic regions for gene quantification. Cells that

met any one of the following criteria were removed: <100,000 total
reads, <1,000 detected genes (CPM > 0), <75% of reads aligned to the
genome or CG dinucleotide odds ratio > 0.5. Cells were classified into
broad classes of excitatory, inhibitory and non-neuronal based on
known markers, and cells with ambiguous identities were removed
as doublets3.
10x v2 and 10x v3 libraries were sequenced on Illumina NovaSeq 6000
(RRID: SCR_016387), and sequencing reads were aligned to the mouse
pre-mRNA reference transcriptome (mm10) using the 10x Genomics
CellRanger pipeline (version 3.0.0; RRID: SCR_017344) with default
parameters. Cells were classified into broad classes of excitatory, inhibitory and non-neuronal based on known markers. Low-quality cells
that fit the following criteria were filtered from clustering analysis.
Different filtering criteria were used for neurons and non-neuronal
cells as neurons are bigger than non-neuronal cells and contain more
transcripts. For scRNA datasets, we excluded neurons with fewer than
2,000 detected genes and non-neuronal cells with fewer than 1,000
detected genes; for snRNA datasets, we excluded neurons with fewer
than 1,000 detected genes and non-neuronal cells with fewer than 500
detected genes. Doublets were identified using a modified version of
the DoubletFinder algorithm51 and removed when the doublet score
was greater than 0.3.
Chromatin accessibility (snATAC-seq) data pre-processing (UCSD).
Paired-end sequencing reads were demultiplexed and aligned to the
mm10 reference genome using bwa52. After alignment, we converted
paired-end reads into fragments and for each fragment, we checked
the following attributes: (1) mapping quality score MAPQ; (2) whether
two ends are appropriately paired according to the alignment flag information; and (3) fragment length. We only keep the properly paired
fragments whose MAPQ (–min-mapq) is greater than 30 with fragment length less than 1,000 bp (–max-flen). Because the reads have
been sorted based on the names, fragments belonging to the same cell
(or barcode) are naturally grouped together, which allows for removing PCR duplicates. After alignment and filtration, we used Snaptools
(https://github.com/r3fang/SnapTools; RRID: SCR_018097) to generate
a snap-format file that contains metadata, cell-by-bin count matrices
of various resolutions and cell-by-peak count matrices.
Filtering cells by transcription start site enrichment and unique
fragments. The method for calculating enrichment at the transcription start site (TSS) was adapted from a previously described
method53. TSS positions were obtained from the GENCODE database
(RRID: SCR_014966). Briefly, Tn5-corrected insertions were aggregated ±2,000 bp relative (TSS strand-corrected) to each unique TSS
genome-wide. Then, this profile was normalized to the mean accessibility ±1,900–2,000 bp from the TSS and smoothed every 11 bp. The
maximum of the smoothed profile was taken as the TSS enrichment. We
excluded any single cells that had fewer than 1,000 unique fragments
or a TSS enrichment of less than 10 for any sample sets.
Doublet removal. After filtering out low-quality nuclei, we used Scrublet (RRID: SCR_018098)54 to remove potential doublets for every sample set. Cell-by-peak count matrices were used as input, with default
parameters.

Preprocessing of the DNA methylation (snmC-seq2) data
(Salk Institute)
Mapping and feature count pipeline for snmC-seq2. We implemented a versatile mapping pipeline (cemba-data.rtfd.io) for all the
single-cell methylome-based technologies developed by our group9,14,30.
The main steps of this pipeline included: (1) demultiplexing FASTQ files
into single-cell files; (2) reads-level quality control; (3) mapping; (4)
BAM file processing and quality control; and (5) final molecular profile generation. The details of the five steps for snmC-seq2 have been

previously described14. We mapped all the reads onto the mouse mm10
genome. After mapping, we calculated the methyl-cytosine counts and
the total cytosine counts in two sets of genome regions for each cell: the
non-overlapping 100-kb bins tiling the mm10 genome, which was used
for methylation-based clustering analysis, and gene body regions ± 2 kb,
which was used for cluster annotation and cross-modality integration.
Quality control and cell filtering. We filtered the cells based on five
quality metrics: (1) the rate of bisulfite non-conversion as estimated
by the rate of methylation at CCC positions (mCCC) < 0.03 (the mCCC
rate reliably estimates the upper bound of the bisulfite non-conversion
rate9); (2) the overall mCG rate > 0.5; (3) the overall mCH rate < 0.2; (4)
the total final reads (combining R1 and R2) > 500,000; and (5) the total
mapping rate (using Bismark55) > 0.5.
Preprocessing and clustering. The clustering steps of snmC-seq2
data were previously described30. In brief, we calculated the posterior mCH and mCG rate based on beta-binomial distribution for the
non-overlapping 100-kb bins matrix. We then selected the top 3,000
highly variable features to perform principal components analysis
(PCA) and find dominant principal components for mCH and mCG
separately. We concatenate principal components from both methylation types together to construct a k-nearest neighbour (KNN) graph,
and ran the Leiden community detection algorithm56 repeatedly to get
the consensus clustering results. The stopping criteria of clustering
considered the number of marker genes, the accuracy of the reproducible supervised model based on the cluster assignments and the
minimum cluster size. We performed the clustering in two iterations to
get the major types and fine-grained types for comparison with other
modalities in further integration.

Computational analysis
Estimation of library size. For estimate of library size, see Extended
Data Fig. 1e. For each dataset, we estimated the total library size, that
is, the number of unique RNA or DNA fragments (F), based on the rate
of duplicate sequence reads. The number of unique mapped reads is
Nunique = F (1 − Bin[0|S, 1/F ]) = F [1 − (1 − 1/F ) S ], where S is the total number of sequenced reads. Using this equation, we numerically solved
for F using the median values of S, Nunique.
Transcriptome analysis
Clustering individual datasets. For transcriptomic analysis, see Fig. 1.
Clustering for each scRNA-seq and snRNA-seq dataset was performed
independently using the R package scrattch.hicat3 (RRID: SCR_018099;
available at https://github.com/AllenInstitute/scrattch.hicat). This
package supports iterative clustering by making successively finer
splits while ensuring all pairs of clusters, even at the finest level, are
separable by stringent differential gene expression criteria3. For the
scRNA 10x datasets, we used q1.th = 0.4, q.diff.th = 0.7, de.score.th = 150
and min.cells = 10. For the snRNA 10x datasets, we used q1.th = 0.3, q.diff.
th = 0.7, de.score.th = 100 and min.cells = 10. For the scRNA SMART
datasets, we used q1.th = 0.5, q.diff.th = 0.7, de.score.th = 150 and min.
cells = 4. For the snRNA SMART dataset, we used q1.th = 0.4, q.diff.
th = 0.7, de.score.th = 100 and min.cells = 4. We further performed
consensus clustering by repeating iterative clustering on a subsample
of 80% of cells, resampled 100 times, followed by final clustering based
on the co-clustering probability matrix. Using this procedure, we could
fine-tune cluster boundaries as well as assess cluster uncertainty.
Next, we removed low-quality and doublet-driven clusters. We performed differential gene expression analysis between every pair of
clusters within each subclass. If any cluster had ≤2 upregulated genes
(fold change > 2, FDR < 0.01, with additional dataset-specific parameters
listed in the previous paragraph) than another cluster, and had a substantially lower average number of detected genes per cell, we flagged
the cluster as low quality and removed it from further analysis. Next,
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if the upregulated genes between any two clusters within a subclass
were predominantly marker genes for a different subclass, and one
of the clusters had a significantly higher average of genes detected
per cell and UMI count, we flagged the cluster as a potential doublet
cluster and removed it from further analysis. These criteria led to the
exclusion of 8.3% of all cells, the vast majority of which came from the
two 10x v3 datasets (scRNA 10x v3 A and snRNA 10x v3 B). While the
10x v3 platform boosts the gene detection for good cells, it does the
same to damaged cells or debris, leading to an increased number of
clusters that were excluded for these datasets.
Joint clustering of multiple transcriptome datasets. To provide a
consensus cell-type taxonomy across all transcriptomic datasets, we
developed an integrative clustering analysis across multiple data modalities. This procedure is available via the harmonize function of the
scrattch.hicat package. Unlike Seurat/CCA57, which aims to find aligned
common reduced dimensions across multiple datasets, this method
directly builds a common adjacency graph using the cells from all datasets, and then applies the Louvain community detection algorithm58. We
extended the cluster merging algorithm in the scrattch.hicat package
to ensure that all clusters can be separated by conserved differentially
expressed genes across platforms. The i_harmonize function, similar to
the iter_clust function in the single-dataset clustering pipeline, applies
integrative clustering across datasets iteratively while ensuring that all
the clusters at each iteration are separable by conserved differentially
expressed genes.
To build a common adjacency matrix incorporating samples from
all the datasets, we first chose a subset of datasets that we used as ‘reference datasets’. For this study, we used the 10x v2 single-cell dataset
from the Allen Institute (scRNA 10x v2 A) and the 10x v3 single-nucleus
dataset from the Broad Institute (snRNA 10x v3 B) as the reference datasets, as both are large datasets that provide comprehensive cell-type
coverage and relatively sensitive gene detection.
The key steps of the pipeline are outlined: (1) perform single-dataset
clustering (Methods described above). (2) Select the anchor cells for
each reference dataset. For each reference dataset (scRNA 10x v2 A or
5, 000
snRNA 10x v3 B), we randomly sampled up to max 100, no.ofclusters
anchor cells per cluster to normalize coverage for each cell type. This
is the only step that uses the dataset-specific clustering information.
(3) Select highly variable genes. Highly variable gene selection and
dimensionality reduction by PCA were performed using the scrattch.
hicat package. We removed principal components with a Pearson correlation coefficient of more than 0.7 with log2(Ngenes). This step was
implemented to mitigate the effect of cell or nucleus quality on gene
expression variability, and to select only biologically relevant principal
components. For each remaining principal component, Z-scores were
calculated for gene loadings. The top 100 genes with an absolute Z-score
greater than 2 were selected as highly variable genes. The highly variable genes from each reference dataset were combined. (4) Compute
KNNs. For each cell in each query dataset, we computed its KNNs (k = 15)
among anchor cells in each reference dataset (scRNA 10x v2 A or snRNA
10x v3 B), based on the highly variable genes selected above. The RANN
package was used to compute KNN based on the Euclidean distance
when the query and reference dataset was the same. To compute nearest neighbours across datasets, we used correlation as a similarity
metric. (5) Compute the Jaccard similarity. For every pair of cells from
all datasets, we computed their Jaccard similarity, defined as the ratio
of the number of shared KNNs (among all anchors cells from all the
reference datasets) divided by the number of combined KNNs. (6)
Perform Louvain clustering. (7) Merge clusters. To ensure that every
pair of clusters are separable by conserved differentially expressed
genes across all datasets, for each cluster, we first identified the top
three most similar clusters. For each pair of such closely related clusters,
we computed the differentially expressed genes in each dataset. We
focus on the conserved differentially expressed genes that are
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significant in at least one dataset, while also having more than twofold
change in the same direction in all but one datasets. We then computed
the overall statistical significance based on such conserved differentially expressed genes for each dataset independently. If any of the
datasets passed our differentially expressed gene criteria described
in the ‘clustering’ section, the pair of clusters remained separated;
otherwise they were merged. Differentially expressed genes were recomputed for the merged clusters, and the process was repeated until
all clusters were separable by the conserved differentially expressed
genes criteria. If one cluster had fewer than the minimal number of
cells in a dataset (4 cells for SMART-Seq and 10 cells for 10x), then this
dataset was not used for differentially expressed gene computation
for all pairs involving the given cluster. This step allows detection of
unique clusters absent in some platforms. (8) Iterative clustering.
Repeat steps 1–6 for cells within each cluster to gain finer-resolution
clusters until no more clusters can be found. (9) Final compilation and
merging of clusters. Concatenate all the clusters from all of the iterative
clustering steps and perform the final merging as described in step 6.
Marker gene selection. For each pair of clusters, we computed the
conserved differentially expressed genes, that is, those which are significantly differentially expressed in at least one dataset, with a twofold
or more change in expression in the same direction among 70% of datasets. To allow computation of differentially expressed genes involving
cell types only present in a subset of datasets, only the datasets with
enough cells (based on min.cells parameter) for both cell types under
comparison were used. We selected the top 50 genes in each direction.
After pooling genes from all pairwise comparisons, we identified a total
of 3,792 marker genes (Supplementary Table 6).
Imputation. To facilitate direct comparison, we projected gene expression of all datasets to the space of a given reference dataset. To do that,
we leveraged the KNN matrices computed during the iterative joint
clustering step to adjust the expression values for systematic differences between datasets. During each iteration of the joint clustering, for
cells in each dataset, we used the average gene expression of their KNNs
among the anchor cells from the reference dataset as the adjusted expression in the reference space. At the top-level clustering, we imputed
the expression for all genes. For each subsequent iteration, we only
imputed the expression of the high-variance genes and the conserved
differentially expressed genes for the clusters defined in that iteration.
We used this iterative approach for imputation because the nearest
neighbours based on the genes chosen at the top level may not reflect
the distinction between the finer types, and the imputed values for the
differentially expressed genes that define the finer types consequently
are not accurate based on these nearest neighbours. Therefore, we
deferred imputation of the differentially expressed genes between the
finer types to the iteration when these types were defined. This method
is provided in the impute_knn_global function in the scrattch.hicat
package3. We imputed the gene expression matrix for both reference
datasets used in the integrative clustering.
Building a cell-type taxonomy tree. We first computed the average
adjusted expression of marker genes for each cluster. This average
was computed using each of the two reference datasets (scRNA 10x
v2 A and snRNA 10x v3 B). Then, the two matrices were concatenated.
We constructed a hierarchy (tree) using the build_dend_harmonize
function in the scrattch.hicat package3.
Dimensionality reduction by UMAP. We performed PCA based on
imputed gene expression matrices of 3,792 marker genes using the 10x
single-nucleus dataset from the Broad Institute as the reference, and
selected the top 50 principal components (93% variance explained).
We removed principal components with Pearson correlation coefficient > 0.6 with the log2(Ngenes) to reduce bias related to the number of

detected genes. UMAP was used to embed the cells in two dimensions
with parameters nn.neighbours = 25 and md = 0.3 (ref. 40).

showed that fine partitions of the data with more than 30–50 clusters
have limited replicability.

MetaNeighbor analysis
For the MetaNeighbor analysis, see Fig. 1g. To quantify replicability of
clusters across the seven transcriptomic datasets, we applied a modified version of unsupervised MetaNeighbor (RRID: SCR_016727)24.
MetaNeighbor uses a neighbour voting algorithm and a cross-dataset
validation scheme to quantify cluster similarity across multiple datasets. It requires a set of unnormalized datasets, a set of cluster labels
and a set of highly variable genes. We used the raw count data for all
cells passing the quality control criteria for the seven single-cell transcriptomic datasets, as well as the labels obtained through independent clustering (Supplementary Table 5). We used the variableGenes
procedure in MetaNeighbor to select 310 highly variable genes that
were detected as highly variable across all datasets.
We defined replicable clusters in a two-step procedure: first, we quantified the similarity between clusters across datasets, then we extracted
groups of highly similar clusters, or ‘meta-clusters’. We used the MetaNeighborUS function to obtain an initial similarity matrix between clusters. By default, cluster similarity is quantified as a one-vs-all AUROC:
given a training cluster (in one dataset), we asked how similar cells from
a test cluster (in another dataset) were to training cells, compared to all
other cells in the test dataset. To make cluster matching more stringent,
we transformed the one-vs-all AUROC matrix into a one-vs-best AUROC
matrix: instead of ranking test cells among all cells from the test dataset,
we only compared them to cells from the best-matching cluster. This
modification ensured that only the best match had an AUROC > 0.5,
facilitating identification of reciprocal best hits. For interpretability
and computational efficiency, we adopted the following convention:
the best-matching AUROC of a cluster was obtained by comparing
it to the second best-matching cluster, the second best AUROC of a
cluster was obtained by computing 1 − AUROC of the best-matching
cluster, and all other clusters obtained an AUROC of 0, as we were only
interested in finding best matches. To extract meta-clusters, we interpreted the one-vs-best AUROC as a graph where nodes are clusters
and edges connect nodes if they are reciprocal best hits. We define
meta-clusters as connected components in this graph. We can obtain
more robust meta-clusters by requiring that best hits exceed some
AUROC threshold. In practice, we noted that one-vs-best AUROC > 0.7
offered a good balance between the number of meta-clusters and
reproducibility strength.
For scalability, we modified MetaNeighbor in the following ways. In
the MetaNeighborUS function, we removed the rank standardization of
the cell–cell similarity network (by setting the parameter fast_version
to TRUE) and the node degree normalization of the neighbour voting,
enabling analytical simplifications of the neighbour voting procedure.
The variableGenes procedure was applied to a random subset of 50,000
cells for datasets exceeding that size.
MetaNeighbor analysis further allowed us to examine the consistency of computational clustering procedures (Fig. 1h). We ran three
widely used single-cell analysis packages25–27 to generate a fine-grained
clustering of each dataset. These cluster analyses were not optimized or
manually curated; instead, we used ‘off-the-shelf’ computational procedures to test the robustness of the results from a relatively straightforward and automated analysis. These clusters are thus expected
to be less biologically meaningful and robust than more customized
procedures, such as our reference clustering that incorporates analysis
of differential expression to validate the biological reality of cell types.
Using the three off-the-shelf cluster analyses, we created a sequence
of increasingly coarse-grained clusterings by iteratively merging pairs
of clusters chosen to maximize the consistency across computational
methods (ARI-merging). Finally, at each level of resolution, we used
MetaNeighbor to calculate the number of clusters that were highly
replicable (AUROC > 0.7) across datasets. The result of this analysis

Cluster analysis for snmC-seq2. For cluster analysis for snmC-seq2,
see Extended Data Fig. 6a, b. We concatenated principal components
from both methylation types (CG and CH) together, and used these to
construct a KNN graph followed by Leiden community detection56. We
repeated the cluster analysis several times to get consensus clustering
results. The stopping criteria of clustering considered the number of
marker genes, the accuracy of the reproducible supervised model
based on the cluster assignments and the minimum cluster size. We
performed the clustering in two iterations to get major types and
fine-grained cell types for comparison with other modalities in further integration.
Two-dimensional embedding using t-distributed stochastic neighbour embedding59 (t-SNE; perplexity = 30) was calculated based on
the top principal components using the implementation from the
scanpy package60.
Cluster analysis for snATAC-seq. For cluster analysis for snATAC-seq,
see Extended Data Fig. 6c, d. We used the snapATAC pipeline48 to identify cell clusters with binarized cell-by-bin matrix in 5-kb resolution as
the input. Cell clusters were annotated to cell type by checking chromatin accessibility along the body of marker genes. Then, another
round of clustering was performed on medial ganglionic eminence
(MGE)-derived and caudal ganglionic eminence (CGE)-derived inhibitory GABAergic interneurons, to identify sub-cell types.

Multimodality integration
For multimodality integration, see Fig. 2.
Computational data integration with LIGER. We used LIGER (RRID:
SCR_018100) to integrate the single-cell transcriptomic and epigenomic data as previously described29, with one modification. We used the
optimizeALS function in the LIGER package to perform joint factorization on all datasets except methylation (seven RNA datasets and one
ATAC dataset) to infer shared (W) and dataset-specific (Vi) metagene
factors and cell factor loadings (Hi). We then used the resulting W to
calculate cell factor loadings (Hi) for the methylation data using the
solveNNLS function in the LIGER package. We found that this strategy
yielded better integration than jointly factorizing all eight datasets,
possibly because the inverse relationship and massive size imbalance
of datasets between methylation and all other datasets complicates
the learning of shared metagenes. Our analysis used only the cells annotated by each data-generating group as passing quality control.
We did not perform any data imputation or smoothing, but simply
normalized and scaled the raw cell-by-gene count matrices from each
dataset using the normalize and scaleNotCenter functions in the LIGER
package. We next used the quantileAlignSNF function with default
settings to perform quantile normalization of cell factor matrices (Hi)
from all eight datasets. Finally, we performed Louvain clustering on
the normalized cell factor matrices (Hi) to obtain joint clusters. We
performed two rounds of integration and joint clustering; in the first
round, we separately integrated all neurons across datasets and all
glia across datasets. We then performed a second round of integration
and clustering separately for each of the four neuronal subclasses:
excitatory IT neurons, excitatory non-IT neurons, MGE interneurons
and CGE interneurons. We used k = 40 factors for the non-neuron analysis, k = 30 for the first-round neuron analysis and k = 20 for all of the
second-round analyses.
Computational integration with SingleCellFusion. SingleCellFusion30 is designed to robustly integrate DNA methylation, ATAC-seq and/
or RNA-seq data. We applied SingleCellFusion iteratively to integrate
all neurons from eight datasets (Supplementary Table 1) and jointly call
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cell clusters. To integrate both the broad and fine-grained cell types,
we performed three rounds of integration. For every cell cluster generated in the previous round, it was further split into smaller clusters by
reapplying SCF on cells in that cluster only. In the first round, we ran
SCF on all neurons from 8 datasets and got 10 broad neuronal clusters.
Rounds two and three generates 29 clusters and 56 more fine-grained
clusters, respectively (Supplementary Table 3).
The procedure comprised four major steps: preprocessing,
within-modality smoothing, cross-modality imputation, and clustering and visualization. (1) For the preprocessing step, we defined a
gene-by-cell feature matrix for each dataset. Droplet-based RNA-seq
features (10x) were log10(CPM + 1) normalized; full-length RNA-seq
(SMART-Seq) features were log10(TPM + 1) normalized. snATAC-seq
data were represented by read counts within the gene body, normalized by log10(RPM + 1), where CPM stands for counts per million reads
mapped (counts normalized), TPM stands for transcripts per million
reads mapped (length normalized) and RPM stands for reads per million
reads mapped (length normalized), respectively. DNA methylation data
are represented by the mean gene body mCH level, normalized by the
global (genome-wide) mean mCH level for each cell. For each dataset,
we only used high-quality cells (passed quality control) and highly
variable genes (n = 4,000–6,300) for further analysis. To select highly
variable genes, for RNA-seq and ATAC-seq datasets, we first removed
genes that were expressed in fewer than 1% of cells. We then divided the
remaining genes into 10 bins according to their mean expression across
cells (CPM). For each bin, except for the one with the most expression,
we selected the top 30% of genes with the most expression dispersion
(variance/mean) as the highly variable genes. For the DNA methylation
dataset, we first selected genes that had more than 20 cytosine coverage in more than 95% of cells, then divided the remaining genes into 10
bins according to their mean normalized mCH level – raw mCH level
normalized by the global mCH for each cell. For each bin, we selected
the top 30% of genes with the most variance as the highly variable genes.
(2) For the within-modality smoothing step, to reduce the sparsity and
noise of feature matrices, we shared information among cells with
similar profiles using data diffusion. The procedure is adapted from
ref. 61 and described in detail in ref. 30. Here we exactly followed ref. 30
with [ndim = 50, k = 30, ka = 5] for all datasets, and [P = 0.7] for RNA-seq
datasets, [P = 0.9] for the DNA methylation dataset and [P = 0.1] for the
ATAC-seq dataset. (3) For the cross-modality imputation by restricted
k-partners (RKP) step, to integrate all eight datasets, we impute the
scRNA 10x v2 A gene features for cells in all seven other datasets. The
imputation was done pairwise between the scRNA 10x v2 A dataset
and each of the other datasets. For each pairwise imputation, we followed the procedure described in ref. 30 with 20 RKP and relaxation
parameter 3 [k = 20, z = 3]. Instead of using Euclidean distance in a
low-dimensional space, we used the (flipped) Spearman correlation
coefficient across genes that were highly variable in both datasets as
the distance metric between cells in two different modalities. (4) For
the clustering and visualization step, we started from a cell-by-feature
matrix, where cells included all cells from eight datasets and features
were highly variable genes of the scRNA 10x v2 A dataset. We reduced
the dimensionality of features into the top 50 principal components.
Next, we performed UMAP embedding40 on the principal component
matrix (n_neighbours = 60, min_dist = 0.5). Finally, we performed Leiden
clustering on the KNN graph (symmetrized, unweighted) generated
from the final principal component matrix (Euclidean distance, k = 30,
resolution = 0.1).
For Extended Data Fig. 7e, we created the embedding of the cluster
centroids using the imputed scRNA 10x v2 A gene features (log10(CPM
+ 1)) for all cells from the eight different datasets generated from SingleCellFusion integration. Clusters are defined by individual dataset
clusterings and by the joint clustering with SingleCellFusion. Cluster
centroids were calculated by the mean imputed scRNA 10x v2 A gene
profiles across cells. After getting a gene-by-cluster matrix, we applied

PCA to reduce to 50 feature dimensions, followed by applying a UMAP
embedding with min_dist = 0.7 and n_neighbours = 10.
For Fig. 2e, to compare molecular signals across data modalities,
all signals were normalized to [0, 1]. This was achieved by first getting
molecular signals by dataset-specific normalization (step 1), followed
by a linear transformation (step 2). In step 1, for SMART-Seq datasets, we
show log10(TPM + 1); for 10x RNA-seq datasets, we show log10(CPM + 1);
for the ATAC-seq dataset, we show log10(RPM + 1) normalized gene body
counts; and for DNA methylation, we show gene body mCH normalized
by global mCH level of each cell. For step 2, we applied a linear transformation to map the range of the signal to [0, 1]. For datasets other
than DNA methylation, we applied the following formula:

xnormalized =

x − xmin
xmax − xmin

where x is the dataset-specific gene-level signal for a cell, xmin and xmax
are defined as the bottom two percentile and the top two percentile of
x across all cells, respectively. For the DNA methylation dataset, we
applied the following formula:

xnormalized = 1 −

x − xmin
,
xmax − xmin

with which signals were still mapped to [0, 1] but flipped—a high signal
on the plot means a low level of DNA methylation. We did this to align
DNA methylation signals with gene expression and open chromatin
signals, because DNA methylation is a repressive marker of gene expression and negatively correlates with it. In these formulas, xmin and xmax
are defined as the bottom 2 percentile and the top 50 percentile of x
across all cells, respectively.
For Fig. 2d, for each gene, cell-level signals were normalized the same
way as described in step 1 of Fig. 2e. Cluster-level signals are the mean
cell-level signals across cells in clusters. After getting gene-by-cluster
matrices this way, for non-DNA methylation datasets, the matrices
were further normalized by the maximum of each cluster (column);
for DNA methylation datasets, no further normalization was done, as
they were already normalized by cell.
For Extended Data Fig. 7g, h, the heat maps show pairwise Spearman
correlation coefficients between the centroids of cells from each cell
type (SingleCellFusion) and each dataset, using the gene expression
levels (log10(CPM + 1); measured or imputed by SingleCellFusion) of
the scRNA 10x v2 A dataset as features. Centroid-level profiles were
computed as the average of cell-level profiles across cells from the same
cell type and the same dataset. The row and column orderings were
the same, generated by a hierarchical clustering on the above-defined
centroid-level features with average linkage and Euclidean distance.
Extended Data Fig. 7g shows the correlations between broad-level
joint clusterings (10 subclasses; SingleCellFusion L0) (Supplementary
Table 8); Extended Data Fig. 7h shows those between fine-level joint
clusterings (56 clusters in total; not all are shown; SingleCellFusion
L2) (Supplementary Table 8) for four example broad-level subclasses
(MGE, CGE, L2/3 IT and L4/5 IT).
For the agreement metric in Extended Data Fig. 7c, we calculated
dataset agreement metrics as described in the LIGER paper29. In brief,
we performed dimensionality reduction using either non-negative
matrix factorization (NMF; for LIGER) or PCA (for SingleCellFusion)
and built a KNN graph for each individual dataset. Then, we built a KNN
graph using the joint latent space from either LIGER or SingleCellFusion
and calculated what fraction of the nearest neighbours from individual
datasets were still nearest neighbours in the joint space. This metric
assesses how well the joint latent space preserves the structure of each
individual dataset. An agreement metric close to 0 indicates poor preservation of structure from individual datasets, while an agreement
metric close to 1 ideally preserves the structure.

For the alignment metric in Extended Data Fig. 7d, we calculated
dataset alignment metrics as described in the LIGER29 and Seurat57
papers, except that we first downsampled cells so that the cluster proportions and the total number of cells were identical across all datasets.
Next, we built a KNN graph using the joint latent space from either
LIGER or SingleCellFusion and calculated what fraction of the nearest neighbours around each point came from each dataset. We then
normalized the metric to be between 0 (no alignment) and 1 (perfect
mixing of datasets). This metric assesses how well the joint latent space
aligns the datasets. Note that maximizing alignment and maximizing
agreement are competing objectives. For example, it is possible to
trivially maximize alignment by randomly mixing cells from all datasets
according to a spherical Gaussian distribution; conversely, one could
trivially maximize agreement by simply assigning non-overlapping
latent representations to all datasets. However, methods must balance these competing objectives to score highly on both alignment
and agreement metrics.
For Extended Data Fig. 7f, to get cluster-level gene signals, we first got
normalized cell-level signals the same way as step 1 of Fig. 2e, followed
by taking the mean cell-level signals across cells in clusters.

Analysis of enhancers
Epigenome cluster level. On the basis of the cell–cell integration in
Fig. 2, to have enough whole-genome coverage of each cell type, we
further merged the co-clusters into a higher level to increase the coverage of each cluster, which we termed as the epigenome cluster level.
DMR calling. For DMR calling in the snmC-seq2 data, we merged
single-cell ALLC files into the pseudo-bulk level for each cluster, and
then used the methylpy62 DMRfind function to calculate mCG DMRs
across all clusters. The base call of each paired CpG site was added up before analysis. In brief, the methylpy function used a permutation-based
root mean square test of goodness-of-fit to identify differentially methylated sites simultaneously across all samples, and then merged the
differentially methylated sites within 250 bp into DMRs. Hypo-DMRs
and hyper-DMRs were then assigned to each sample by examining
the residue of observed counts from the expected counts. We also
filtered the DMRs by requiring that the maximum difference of mCG
rate between clusters was larger than 0.3.
snATAC peak calling. We called peaks according to the ENCODE
ATAC-seq pipeline (https://www.encodeproject.org/atac-seq/). For
every cell cluster, we combined all properly paired reads to generate
a pseudo-bulk ATAC-seq dataset for individual biological replicates. In
addition, we generated two pseudo-replicates, each of which included
half of the reads from each biological replicate. We called peaks independently for each of these four datasets, as well as for a pool of the
data from both biological replicates. Peak calling was performed on the
Tn5-corrected single-base insertions using MACS263 (RRID: SCR_013291)
with parameters: –shift −75–extsize 150–nomodel–call-summits–
SPMR–keep-dup all −q 0.01. We extended peak summits by 250 bp
on either side to a final width of 501 bp for merging and downstream
analysis. To generate a list of reproducible peaks, we kept peaks that
(1) were detected in the pooled dataset and overlapped 50% or more of
the peak length with a peak in both individual biological replicates, or
(2) were detected in the pooled dataset and overlapped 50% or more
of the peak length with a peak in both pseudo-replicates.
To account for differences in performance of MACS2 based on read
depth and/or the number of nuclei in individual clusters, we converted
MACS2 peak scores (−log10(q value)) to score per million (SPM)64 and
kept peaks with SPM > 2. We only kept reproducible peaks on chromosomes 1–19 and both sex chromosomes, and filtered ENCODE mm10
blacklist regions65 (http://mitra.stanford.edu/kundaje/akundaje/
release/blacklists/mm10-mouse/mm10.blacklist.bed.gz). Finally, since
snATAC-seq data are relatively sparse, we selected only elements that

were identified as open chromatin in a significant fraction of the cells
in each cluster. To this end, we defined a set of background regions,
matching the number of peak regions for each cell type, by randomly
selecting regions from the genome while excluding accessible sites
from the ENCODE registry of cis-regulatory elements (https://screen.
encodeproject.org/). We calculated the fraction of nuclei for each cell
type that had ATAC fragments mapping to the background regions.
Next, we fitted a zero-inflated beta model and empirically identified
a significance threshold of FDR < 0.01 to filter potential false-positive
peaks. Peak regions with FDR < 0.01 in at least one of the clusters were
included in the downstream analysis.
We used ‘bedtools intersect’ with the ‘-wa -u’ parameter to calculate
DMR and ATAC peak overlaps66 (RRID: SCR_006646).
Saturation analysis. To investigate the efficiency of regulatory element identification in terms of cell number in the epigenomic data,
we did a saturation analysis using the two most abundant cell types:
the L2/3 IT and the L6 CT excitatory neurons. The total reads assigned
to these two cell types were comparable to bulk-seq. We subsampled
a different number of cells without replacement in each cluster three
times when we had enough cells, and used cells from each replicate
separately when possible. In the last group, we used all of the cells for
each cell type as a maximum reference. For methylome data, we called
DMRs between L2/3 IT and L6 CT within each cell number group. Peaks
were called for each cell-type group.
REPTILE enhancer prediction. We performed enhancer prediction
using the REPTILE35 algorithm. The REPTILE is a random-forest-based
supervised method that incorporates different sources of epigenomic profiles with base-level DNA methylation data to learn and then
distinguish the epigenomic signatures of enhancers and genomic
background. We trained the model in a similar way as in previous
studies35,67 using CG methylation, chromatin accessibility of each
epigenome cluster and mouse embryonic stem cells. The model was
first trained on mouse embryonic stem cell data and then predicted
a quantitative score that we termed enhancer score for the DMR of
each cell type. The positives were 2-kb regions centred at the summits
of the top 5,000 EP300 peaks in mouse embryonic stem cells. Negatives included randomly chosen 5,000 promoters and 30,000 2-kb
genomic bins. The bins have no overlap with any positives or promoters67. Methylation and chromatin accessibility profiles in bigwig format
for mouse embryonic stem cells were from the mouse ENCODE project67. The mCG rate bigwig file was generated from cell-type-merged
ALLC files using the software ALLCOOLS (https://lhqing.github.io/
ALLCools). For chromatin accessibility of each cell type, we merged
all fragments from snATAC-seq cells that were assigned to this cell
type in the integration analysis and used ‘deeptools bamcoverage’ to
generate CPM-normalized bigwig files. The bin size for all bigwig files
was 50 bp.
Motif enrichment analysis. We used 724 motif position weight matrices (PWMs) from the JASPAR 2020 CORE vertebrates database68,
where each motif was able to assign corresponding mouse transcription factor genes. For each set of REPTILE-predicted enhancers, we
standardized the region length into centre ± 250 bp and used the FIMO
tool from the MEME suite69 to scan the motifs in each enhancer with log
odds P value < 10−6 as the threshold of the motif hit. To calculate motif
enrichment, we used the adult non-neuronal mouse tissue DMRs70 as
background regions. We subtracted enhancers in the region set from
the background and then scanned the motifs in background regions
using the same approach. We then used Fisher’s exact test to find motifs
enriched in the region set and the Benjamini–Hochberg procedure to
correct multiple tests. Transcription factors with significant motif
enrichment were grouped by TFClass71 classification. Genes within the
same group shared very similar motifs.
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Cluster validation analysis
For cluster validation analysis, see Fig. 4.
Downsampling analysis of cluster number. For downsampling analysis of cluster number, see Fig. 4a–d.
Preprocessing was done in the same way as described in the section
’Computational integration with SingleCellFusion’. After preprocessing, we obtained a gene-by-cell feature matrix for each dataset. Only
neuronal cells passing quality control (Supplementary Table 1) and
highly variable genes for each dataset were included.
Clustering. Clustering (Fig. 4a) required three steps. We first reduced
feature dimensions by PCA (n = 50). We then built a KNN graph (k = 30)
between cells using the Euclidean distance in the principal component space. We finally applied the Leiden clustering algorithm with
a fixed-resolution parameter (r = 6). For each dataset, we report the
number of clusters as a function of the number of cells randomly downsampled from the full dataset. Error bars show the s.e.m. of (n = 10)
rounds of downsampling.
Clustering with within-dataset cross-validation. This analysis
(Fig. 4c) aimed to estimate the optimal number of clusters of a dataset,
by testing which clustering granularity best preserves the gene-level
features of cells. For a given dataset, a gene-by-cell matrix, we first
randomly split gene features into two sets, for clustering and validation, respectively. To avoid any potential linkage, the split was done
by separating chromosomes into two sets, such that genes from the
same chromosomes were always in the same set. We then performed
Leiden clustering (as described in the methods related to Fig. 4a) on
all cells using the clustering feature set only, with different clustering resolutions. After clustering, every cell in the dataset received a
cluster label. We next randomly separated those cells into training and
testing sets. Using training-set cells, we trained a supervised model
to predict the validation set gene features based on cluster assignments. The model was trained by minimizing the MSE between the
model prediction and the data. This is equivalent to predicting the
gene features of a cell as its cluster centroid. Finally, we evaluated the
model performance by calculating the MSE for the cells in the test set.
This is equivalent to estimating the mean squared distance between
individual cells in the test set and the cluster centroid calculated using
the training set. As a function of the number of clusters (by varying the
resolution parameter in Leiden clustering), we observed a U-shaped
curve of the MSE. The minimum point of the curve represents the most
plausible clustering resolution. Applying this scheme to each dataset
and different downsampling levels of cells, we report in Fig. 4c the number of clusters as a function of the number of cells, for each dataset.
For robustness, random splitting of gene features was repeated n = 5
times; random splitting of cells was repeated n = 5 times with k = 5-fold
cross-validation each time.
Clustering with cross-dataset cross-validation. Extending the
within-dataset clustering cross-validation scheme used in Fig. 4c,
we developed a cross-dataset cross-validation method (Fig. 4d), by
combining the previously described within-dataset cross-validation
method with a joint clustering method: SingleCellFusion. First, similar
to within-dataset cross-validation, we randomly split gene features
into clustering and validation sets for all datasets. We then generated
integrated clusterings across data modalities by applying SingleCellFusion on all cells and on half of the gene features (the clustering feature set). After clustering, we estimated the MSE of clustering on the
validation feature set as described above for each dataset on its own.
Applying this scheme to different downsampling levels of cells, we
report in Fig. 4d the number of clusters as a function of the number of
cells from each dataset.

Integrated analyses: trade-off between replicability and resolution
and cluster consistency. For integrated analyses, see Fig. 4e, f. We collected the clusters obtained with the four integrative clustering methods described previously (Conos, LIGER, RNA consensus clustering
from Fig. 1 and SingleCellFusion), as well as the ‘subclass’ level from the
independent clustering of the RNA datasets. Each integrative method
returned clusters at two granularity levels. We named the coarser level
of clustering L1 and the finer level of clustering L2 clusters. We focused
our analyses on the neuron clusters of the transcriptomic data, as we
wished to investigate the agreement of neuron cluster hierarchies.
To quantify replicability, we used the same modified version of MetaNeighbor, the same datasets and the same variable genes as defined
above (see ‘MetaNeighbor analysis’). We used the one-vs-best AUROC
to obtain cluster similarity scores, then computed an average AUROC
score per integrated cluster (averaged over every pair of datasets in
which the cluster is present). For every method, we reported the median
AUROC across integrated clusters as the final reproducibility score. To
quantify the overall similarity of the clustering results, we computed
the adjusted Rand index. When necessary, we restricted the adjusted
Rand index computation to the intersection of labelled cells (the intersection being recomputed for every pair of methods).
Conos analysis. To evaluate the extent to which different cell subpopulations were supported by different platforms, we assessed the
difference in the ability to recover the corresponding cell with and
without within-platform comparisons. The clustering of cells was performed using Conos37 (Fig. 4g, h), using walktrap community detection
to identify hierarchical cell populations. The stability of the hierarchical
clusters was estimated as follows: 20 random cell subsampling rounds
were performed, each sampling 95% of cells from each dataset, and
repeating the walktrap hierarchical clustering procedure. For each
node in the original walktrap tree, we evaluated stability as a minimum
of specificity and sensitivity relative to the ensemble of subsampled
trees by finding the best-matching subtree. To evaluate the ability to
recover subpopulations based on cross-platform comparisons only, we
removed within-platform edges (those connecting datasets generated
by the same platform) in the joint graph (generated by Conos). In this
way, the subpopulation was detected only based on mapping to the
other platform. The modified approach facilitates grouping of cell
populations that are common in the different platforms, as it removes
the platform-specific information in the joint graph.
To assess the similarity of the expression profiles detected by different platforms for a given cell type (Fig. 4h), we used Jensen–Shannon
divergence to assess the overall similarity of gene expression patterns
between the four RNA-seq platforms (scRNA 10x v3 A, snRNA 10x v3
A, scRNA SMART and snRNA SMART). Specifically, 1,000 cells were
sampled from each cell type for each platform. If the number of cells
from a cell type was fewer than 1,000 cells, sampling with replacement was performed. Cell types that accounted for less than 1% (fewer
than 300 cells) in any specific platform were omitted. The molecules
detected for each gene were then aggregated across all sampled cells
for each cell type in each platform. The counts were normalized by the
total number of molecules for each cell type or platform, and Jensen–
Shannon divergence was calculated.

Reporting summary
Further information on research design is available in the Nature
Research Reporting Summary linked to this paper.

Data availability
The BICCN MOp data (RRID: SCR_015820) can be accessed via the
NeMO archive (RRID: SCR_016152) at: https://assets.nemoarchive.
org/dat-ch1nqb7. Visualization and analysis resources can be found

at: NeMO analytics (https://nemoanalytics.org/), Genome browser
(https://brainome.ucsd.edu/BICCN_MOp) and Epiviz browser (https://
epiviz.nemoanalytics.org/biccn_mop).

Code availability
The codes used for data analysis: scrattch.hicat (hierarchical, iterative
clustering for analysis of transcriptomics) for RNA clustering (https://
github.com/AllenInstitute/scrattch.hicat); SnapTools for ATAC-seq
analysis (https://github.com/r3fang/SnapTools); YAP (Yet Another
Pipeline) and ALLCools for DNA methylation (snmC-seq2) mapping
and cluster-level aggregation (https://github.com/lhqing/cemba_data;
documentation: cemba-data.rtfd.io; https://lhqing.github.io/ALLCools); MetaNeighbor for cluster reproducibility analysis (https://
github.com/gillislab/MetaNeighbor-BICCN); LIGER for multimodal
integration, embedding and clustering (https://github.com/welch-lab/
liger); SingleCellFusion for multimodal integration, embedding and
clustering (https://github.com/mukamel-lab/SingleCellFusion); Conos
for cluster reproducibility analysis (https://github.com/kharchenkolab/
conos); STAR v2.5.3 for RNA-seq alignment49; and Bismark for DNA
methylation (snmC-seq2) alignment55.
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Extended Data Fig. 2 | Cluster membership and gene expression
consistency across scRNA-seq and snRNA-seq datasets. a, Pearson
correlation of gene expression of 3,792 cell-type-specific marker genes across
cell types between every pair of datasets. Each violin plot shows the
distribution of correlation values for all genes between a pair of datasets. Most
genes have highly conserved gene expression patterns at the cell-type level
among all datasets (average correlation of 0.856 across all pairs of
comparisons). The most consistent datasets are scRNA 10x v2 and v3 (average
correlation of 0.95), while snRNA 10x v3 B is also highly similar to both scRNA
10x v2 and v3 datasets. Overall, we found the differences between single-cell
and single-nucleus datasets to be more significant than SMART-Seq versus 10x
platform differences. b, Number of genes detected per cell or nucleus by each
transcriptomic assay as a function of sequencing depth, as determined by
downsampling analysis (n = 79 independent biological samples; see
Supplementary Table 1). c, Gene detection frequency (sensitivity) at each gene
expression range for each dataset (n = 79 independent biological samples; see
Supplementary Table 1). Expression of all genes in each cell type was binned
based on the average logCPM in scRNA 10x v2 and snRNA 10x v3 B datasets.
Single-cell datasets overall have higher sensitivity for gene expression than
single-nucleus datasets, with the exception of the snRNA 10x v3 B dataset,
which was more sensitive than the scRNA 10x v2 A dataset. For weakly
expressed genes, the gene detection frequency can vary dramatically between
datasets. For these genes, scRNA SMART was the most sensitive, followed by
10x v3 datasets, all of which showed very robust gene detection. Note that
sequencing depth was not considered for this analysis. For b, c, box-andwhisker plots show the median, the interquartile range (IQR) (25–75th
percentile), and the whiskers show the smaller of the data range (minimum to
maximum) or 1.5 times the IQR. d, Comparisons between clustering analysis of
individual datasets with the consensus clusters derived from seven
transcriptomic datasets. The size of the dot indicates the number of

overlapping cells, and the colour of the dot indicates the Jaccard index (number
of cells in intersection/number of cells in union) between the independent and
joint clusters. e, Comparison of the relative gene expression of marker genes
across all cell types between corresponding SMART-Seq and 10x v2 datasets.
To compare gene expression directly between SMART-Seq and 10x datasets,
which differ in experimental platforms, gene expression quantification
software and gene annotation reference, for each gene, we normalized the
average log 2(CPM + 1) values at the cluster level in the range [0,1] by subtracting
the minimum value and then dividing by the maximum value for that gene. The
smooth scatter plot corresponds to the normalized gene expression for all
marker genes across all types in two datasets, with their overall Pearson
correlation (across all marker genes and cell types) highlighted. f, Differential
enrichment of transcripts in single cells (x axis) versus single nuclei (y axis)
across four platforms. Non-coding RNAs such as Malat1 are enriched in nuclei.
g, Distribution of the estimated nuclear localization fraction for all mRNAs
based on comparison of the snRNA and scRNA 10x v2 datasets22. To calibrate
the differences among cell types, we sampled the same number of cells in each
cluster for both datasets, and aggregated all the cells for estimation. We plot
the empirical cumulative density function for the marker genes and all other
genes separately. The fraction of nuclear mRNAs for five selected genes are
shown along the x axis. As expected, mitochondrial genes such as mt-Nd3 have
almost no nuclear localization, whereas Vip is significantly enriched in the
nucleus. A selected set of 3,792 cell-type-specific marker genes (see Methods
section ‘Marker gene selection’) have a lower nuclear fraction relative to the
other genes (median 16.6%, compared with 21.9% for non-marker genes).
h, Cluster resolution analysis, showing the number of clusters identified in
each transcriptomic dataset with a fixed cluster procedure and resolution
(r = 6) as a function of the number of sequenced reads, and using the same
number of cells for each of the 10x or SMART-Seq datasets. The shaded region
shows the s.e.m. from cross-validation with n = 5 independent data partitions.
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Extended Data Fig. 3 | Correspondence between the MOp consensus
RNA-seq cell-type taxonomy and previously published VISp/ALM cell-type
taxonomy3. a, Cells from all scRNA and snRNA MOp datasets were mapped to
the most correlated VISp/ALM cell types based on VISp/ALM cell-type markers.
The size of the dots indicates the number of overlapping cells, and the colour
indicates the Jaccard index (number of cells in intersection/number of cells in
union). MOp L5 ET types are mapped predominantly to L5 pyramidal tract (PT)
ALM types in the VISp/ALM study. Note that we have adopted the nomenclature
‘extratelencephalically projecting (ET)’ for these neurons, instead of the

previously used ‘pyramidal tract (PT)’, owing to the fact that not all of these
neurons project to the pyramidal tract leading to the spinal cord. b, Three L5 PT
ALM types can be divided into two groups with distinct projection patterns.
Cells in the pink group project to the medulla and have been functionally
associated with movement initiation, while the cells in the green group project
to the thalamus, associated with movement planning. Adapted from Economo
et al. (2018)18. c, Enlarged view of the correspondence between MOp L5 ET
types and VISp/ALM L5 PT types. Two subsets of medulla-projecting (pink) and
thalamus-projecting (green) L5 PT cells are highlighted.

a

ALM/Visp (Tasic et al., 2018)
L5 PT cells
Medulla-projecting

Projection class
Cell type

Thalamus-projecting

b
scRNA
SMART

Present study - L5 ET cell types
snRNA SMART

snRNA 10x v3 B

scRNA 10x v3 A

Ryr1
Fgf10
Tgfbr1
Ppp1r14c
Pvalb
Hsd11b1
Teddm3
Igsf3
Mdga1
Chn2
Stk17b
Kcnmb2
Ccbe1
Erg
Wnt4
Rell1
Htr7
Colgalt2
Onecut2
Aldoc
Met
Kcnh5
Htr2c
Vav3
Prrg1
Bace2
Samd5
Atp10a
Ltbp1
Col23a1
S100a1
Grp
Stard8
Rnf207
G0s2
Prss23
Mctp2
Qrfpr
Kcnip1
Blnk
Wipf3
Tmem159
Ovol2
Cntnap4
Scd1
Matn2
D030068K23Rik
Plekha2
Pdlim1
Opn3
Ust
Sphkap
Mgat4c
Neurod6
Cntnap5b
Kcnt2
Cdh13
St6galnac3
Kcnab1
Lypd1
Crym
St6galnac5
Pip5k1b
Pcdh19
Man1a
Stxbp6
Shisa9
March1
Rgs6
Nckap5
Hs3st4
L3mbtl4
Alcam
Syt17
Rasgef1b
Grik4
Ramp3
Dpyd
Cntnap5c
Gfra2
Fstl5
Zfp804b
Necab1
Krt12
Fam20a
Cdh4
Slco2a1
Adamts2
Npsr1
Mei4
Grin3a
Ptpro
Cemip
Dcc
Col6a1
Il1rapl2
Reln
Slc26a4
Mgat5b
Trpc7
Trabd2b
Vgll3
Dnah9
Sema6a
Ptgfrn
Rnf152
Cxcl12
Tmem91
Npnt
Kctd8
Pdzrn3
Sv2c
Pou3f2
Sorcs3
Slc24a3
Col8a1
Cbln2
Sema3c
Olfm3
Tshz2
Egfem1
Gpc5
Vwc2l

Min

Max

RNA-Seq gene expression (normalized for each gene)
Extended Data Fig. 4 | Marker genes for L5 ET cell types. a, Heat map showing
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on correspondence in Extended Data Fig. 3c.
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Extended Data Fig. 6 | Epigenomic cell types and multimodal integration.
a, Cell-type clusters from single-nucleus methyl-C-Seq (snmC-seq2 (refs. 9,14))
for 9,876 MOp nuclei are represented in a two-dimensional projection. Labels
indicate broad cell types; the colours show finest cluster resolution. b, Non-CG
DNA methylation level (normalized mCH) for each cell at gene bodies of
markers of major cell types. Actively expressed genes have low mCH, indicated
by the coloured bars extending downward. Highly methylated (repressed)
genes appear white in this plot. c, Two-dimensional projection of cell-type
clusters from snATAC-seq11 profiles for 81,196 cells. d, Gene body chromatin
accessibility (total snATAC-seq read density, log(CPM + 1)) for marker genes.
For b and d, each bar represents one cell. The abbreviations of cell type are as in

Fig. 2. CGE/MGE, caudal/medial ganglionic eminence-derived inhibitory cells.
e, f, Integrated, multimodal UMAP embeddings (SingleCellFusion (e); LIGER
(f)) coloured by the clusters assigned in separate analysis of each dataset. Each
panel shows the cells from a single dataset. g, Integrated analysis of major cell
classes by LIGER. Cells in each of the five cell classes are separately integrated,
illustrating fine-grained resolution of integrated data. h, Number of cells in
each of 56 multimodality cell types (SingleCellFusion; L2), ranked by cluster
size. i, j, Number of cells for 56 integrated clusters (SingleCellFusion L2 (i);
LIGER L2 ( j)), as well as the corresponding coarser clusters (L1, L0). Cluster
order and colour scheme are as shown in Fig. 2.
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Extended Data Fig. 7 | Validation of multimodal integration of
transcriptomic and epigenomic data. a, Confusion matrices comparing
integrated clusters generated by SingleCellFusion versus clusters generated by
LIGER (left), and comparing SingleCellFusion versus consensus transcriptomic
taxonomy (right). b, Confusion matrix comparing integrated clusters
(SingleCellFusion L2) with single-modality clustering for every dataset.
c, d, Agreement and alignment metrics29 characterize the fidelity of the joint
low-dimensional embedding for LIGER and SingleCellFusion. Agreement
measures the fraction of KNNs for each dataset that are still nearest neighbours
in the low-dimensional embedding. A high value of the agreement metric thus
indicates preservation of each dataset’s internal structure in the joint
embedding. Alignment measures the mixing of datasets in the joint
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low-dimensional space, and is a normalized measure of the mean number of
KNNs that come from each of the datasets. e, Embedding of multimodality
cluster centroids. The black dots are cluster centroids of integrated clusters
(SingleCellFusion); coloured dots are cluster centroids of individual datasets.
f, Molecular signatures at the gene body of Lhx9, a developmentally expressed
transcription factor, across cell types (n = 29; SingleCellFusion L1). We found
enrichment of mCG and mCH in L6b neurons with no corresponding RNA or
ATAC-seq signal. g, Spearman correlation matrix for cluster centroid gene
expression (measured or imputed) across major cell subclasses for each
dataset (SingleCellFusion L0). h, Correlation for subsets of inhibitory (CGE and
MGE) and excitatory (L4/5 IT and L2/3 IT) neuron types using fine-grained
integrated clusters (SingleCellFusion L2).
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Extended Data Fig. 8 | MetaNeighbor and cross-validation analysis
of cluster reproducibility. a, Heat map showing replicability scores
(MetaNeighbor AUROC) at the subclass level of the independent clusterings of
seven RNA-seq datasets. High AUROC indicates that the cell-type labels in one
dataset can be reliably predicted based on the nearest neighbours of those
cells in another dataset, together with the independent cluster analysis of that
dataset. b, Scheme for within-dataset and across-dataset cross-validation.
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c, d Within-dataset cross-validation analysis for each dataset, either using the
full set of cells (c) or using a random sample of 5,000 cells (d). In each plot, the
black curve shows training error, while the coloured U-shaped curve shows the
test set error, with a minimum at the cluster resolution that balances
over-fitting and under-fitting. The shaded region shows the s.e.m. based on
cross-validation with n = 5 data partitions. e, Transcriptomic platform
consistency is assessed by cross-dataset cluster stability analysis (Conos37).

